TNDM | tickerfilter.com

Fundamental analysis

41%

Profitability 25%

Dept financing 50%

Liquidity 40%

Performance 55%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.13%

1 Month

-8.82%

3 Months

-51.95%

6 Months

-46.95%

1 Year

-52.85%

2 Year

-56.29%

Key data

Stock price

$17.47

P/E Ratio

0.00

DAY RANGE

$17.25 - $18.22

EPS

-$0.71

52 WEEK RANGE

$15.75 - $53.66

52 WEEK CHANGE

-$52.38

MARKET CAP

2.366 B

YIELD

N/A

SHARES OUTSTANDING

65.465 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

04-30-2025

BETA

1.52

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,320,588

AVERAGE 30 VOLUME

$1,547,090

Company detail

CEO: John F. Sheridan
Region: US
Website: tandemdiabetes.com
Employees: 2,600
IPO year: 2007

Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

Tandem Diabetes Care, Inc. designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system. It also offers t:connect, a web-based data management application, continuous glucose monitoring, and supported blood glucose meters.

TNDM - Tandem Diabetes Care Inc